(RTTNews) - RenovoRx, Inc. (RNXT), a life sciences company developing oncology therapies, has enrolled its first patient in PRISM-TAMP, "PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP," an investigator-initiated trial (IIT) sponsored by the University of
European Central Bank officials are probably in for a heated debate when they set borrowing costs in late October, according to Governing Council member Ante Zigman.
A new analysis of federal earnings data measures how much students who received federal financial aid earned four years after graduating. Our graphics reporter Arfa Momin studied the data to see when a graduate’s major and college mattered most to earnings.
Arfa Momin, Nour Idriss, Rafaela Balster and Edward Vega